作者: Thomas K. Varghese
DOI: 10.1007/978-3-319-12553-4_7
关键词: Oncology 、 Population ageing 、 Cancer 、 Internal medicine 、 Medicine 、 Mass screening 、 Lung cancer surgery 、 Comparative effectiveness research 、 Disease 、 Lung cancer 、 Pancreatic cancer
摘要: Lung cancer accounts for more deaths than breast, prostate, colorectal and pancreatic combined. With an aging population, greater intensity of care, the need care growing number survivors, comparative effectiveness research opportunities will continue to emerge this disease. In chapter, we focus on CER in lung surgery from vantage point those factors directly influenced by surgeon, patient healthcare system.